May 11, 2010 · Leave a comment
May 11, 2010 (CHAPEL HILL, NC) Paul Meade, founder and president of Thought Leader Select, a North Carolina firm dedicated to key opinion leader (KOL) development solutions for the biopharmaceutical industry, received a master of public health degree from the University of North Carolina at Chapel Hill on May 8, 2010.
The Gillings School of Global Public Health at UNC awarded Meade, a 25-year veteran of the pharmaceutical industry, with a master of public health degree and a certificate in public health ethics in the Public Health Leadership Program. Meade’s research report, “How Volunteer Community Organizations Can Assist State Public Health Departments During Pandemic Influenza,” explored specific possibilities for the Civil Air Patrol, a volunteer non-profit national organization and an auxiliary of the United States Air Force, to assist state public health officials during widespread outbreaks of influenza.
The master of public health degree is Meade’s second master’s degree. He earned a master of science in biomedical science from the University of Guelph (Canada) in 1977, following his bachelor of science degree in biology and chemistry from Acadia University (Canada) in 1971.
During his 25-year career in the pharmaceutical industry, Meade served in a variety of leadership positions at Merck and GlaxoSmithKline. During his ten years at Merck, Meade worked his way from a sales representative position to director of marketing planning for Merck-Frosst in Canada. At GSK, Meade served in several leadership roles, culminating in a position as worldwide commercial director of predictive medicine.
After leaving the pharmaceutical industry, Meade founded two firms, Clear Point Health and Thought Leader Select, in 2004 and 2006, respectively. Clear Point Health provides research and consulting services to the biopharmaceutical industry, including marketing planning and consulting for research and development, clinical operations, and medical affairs. Thought Leader Select delivers solutions for more sophisticated and effective management of biopharmaceutical industry relationships with thought leaders in the health care community at large, including physicians, nurses, physician assistants, pharmacists, veterinarians, and clinical researchers.
“Earning my MPH has enabled me to pursue new areas of healthcare research, such as policy and ethics” stated Meade. “Throughout my career, I have always strived to do what is right, for both my clients in the healthcare industry as well as with my employees.” Meade also stated, “with the need for greater transparency between the biopharmaceutical industry, the medical community, and the general public, my training in ethics will help me keep our customers in compliance with guidelines and regulations.”
About Thought Leader Select
Thought Leader Select is a specialty firm focused on providing solutions—research, technology tools and focused advice/consulting—for more effective KOL engagement and deployment in the healthcare industry. Thought Leader Select’s groundbreaking work bridges the areas of research, communications and technology. With more than 70 years of combined experience working in and with the pharmaceutical industry, Thought Leader Select is addressing needs for better engagement and more sophisticated deployment of KOLs during drug development and the life cycle of the brand.
Director of Global Marketing and Client Relations